“Temporary hold” on the Oxford-AstraZeneca vaccine – WHO Press Conference (8 Feruary 2021)

About This Source - United Nations

The United Nations (UN) was established after World War II with the aim of preventing future wars. The organization is financed by assessed and voluntary contributions from its member states.

The UN’s chief administrative officer is the Secretary-General, currently Portuguese politician and diplomat António Guterres, who began his five year-term on 1 January 2017.

 

Recent from United Nations:

  • Iraq: ‘safe environment needed for credible elections’- Security Council Briefing
  • Vaccine Solidarity, Somalia Statement, Sahel & other topics – Daily Briefing (16 February 2021)
  • Vaccines for emergency use – WHO Press Conference (15 February 2021)
  • United Nations published this video item, entitled ““Temporary hold” on the Oxford-AstraZeneca vaccine – WHO Press Conference (8 Feruary 2021)” – below is their description.

    WHO Director-General Tedros Ghebreyesus expressed concern following an announcement by South Africa that it was putting a “temporary hold” on the rollout of the Oxford-AstraZeneca vaccine.

    Speaking at a press conference in Geneva today (08 Feb), Tedros said the decision by South Africa was made after a study showed the Oxford-AstraZeneca vaccine was “minimally effective at preventing mild to moderate disease caused by a variant first identified in South Africa.” However, he said there were some “important caveats; “given the limited sample size of the trial and the younger, healthier profile of the participants, it is important to determine whether or not the vaccine remains effective in preventing more severe illness.”

    Professor Salim Abdool Karim, Co-chair of South Africa’s Ministerial Advisory Committee on COVID-19, said the study which looked at only mild and moderate infections raised concerns, “not because we were not expecting some diminishing activity, but it was the level to which it was diminished.” He added, “And so now, we are unclear and uncertain about the efficacy of the vaccine in preventing hospitalization and severe disease. We know from the overall trial that the AstraZeneca vaccine is effective against other pre-existing variants, we’re just not confident about its efficacy against the 501Y.V2 variant.”

    Dr Tedros said WHO expects to make a decision in the next few days on the emergency use listing of the Oxford-AstraZeneca vaccine, for the two sites in India and the Republic of Korea which will produce it for COVAX. He added, “We are committed to using all available data to make those assessments. In the meantime, COVAX continues to prepare for its first quarter distribution, and to add to its vaccine portfolio.”

    Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), said the mutation of the virus was anticipated and “this is one of the values actually of doing the science.” He said, “It allows us to essentially to look into the future, to look at possibilities that may occur and to help us look out for mutations that would be of concern.”

    Dr Kate O’Brien, Director of WHO’s Department of Immunizations, Vaccines and Biologicals said, “Everybody’s looking at the data right now. And there are a range of ways that this can be approached. But I think what was most clear that came out from the SAGE meeting is that in looking at the evidence on the AstraZeneca vaccine across a number of trials, it is very clear that it has efficacy against severe disease, hospitalizations and deaths. Among the variants and different variants, there is some reduction, some indications of reduction in the efficacy, some more, some less, depending on which variant, which population, and also of the neutralizing antibody responses. But we also have evidence that there is the likelihood that the retention of meaningful impact against severe disease is a very plausible scenario for the product against the B1351 variant.”

    Turning to the Ebola situation in the Democratic Republic of the Congo (DRC), Tedros said a new case of Ebola was reported near the city of Butembo in the North Kivu province. He said the victim who lost her life was a was married to an Ebola survivor. He said thanks to the enormous capacity built during the latest outbreak, provincial health authorities have significant experience in responding to Ebola and in preventing onward transmission. He added, “More than 70 contacts have been identified, and WHO is supporting local and national authorities to trace them and provide care where needed.”

    United Nations YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: AstraZeneca

    AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

    3 Recent Items: AstraZeneca

  • Victoria awaiting lockdown update, Astrazeneca vaccine approved in Australia | 9 News Australia
  • AstraZeneca vaccine doses ready to roll out in Australia in early March, company says | ABC News
  • Why are Italians refusing the AstraZeneca vaccine? | ITV News
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • “We want to have fun”: Martinique holds Carnival despite Covid-19 restrictions
  • Italian PM Draghi to outline plan to rescue country from virus crisis
  • Is New Government ‘Get Testing’ Slogan Giving False Sense of Security? | This Morning
  • Gucci stumbles as Kering gears up for brand’s 100th year
  • Live: News conference on COVID-19 measures for Tokyo Olympics
  • In This Story: India

    India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world. New Delhi is the capital.

    It has an exceptionally diverse population, with Hindus, Muslims, Christians, Sikhs, Buddhists, Jains and other religions speaking over 21 recognised languages.

    2 Recent Items: India

  • India glacier disaster: Spotlight on Himalayan infrastructure projects
  • At least 49 passengers killed after bus veers off road in India
  • In This Story: South Africa

    South Africa is a country on the southernmost tip of the African continent, marked by several distinct ecosystems. Inland safari destination Kruger National Park is populated by big game. The Western Cape offers beaches, lush winelands around Stellenbosch and Paarl, craggy cliffs at the Cape of Good Hope, forest and lagoons along the Garden Route, and the city of Cape Town, beneath flat-topped Table Mountain.

    2 Recent Items: South Africa

  • Coronavirus: Alberta officials provide update on latest COVID-19 numbers in the province | LIVE
  • Rise of Variants Sparks Push for All-in-One Covid Vaccines
  • Leave a Comment